» EUTox » Theses                  



The following PhD Students sucessfully completed their thesis within the EUTox Work group:


B. Näsström: Lipoprotein lipase in hemodialysis patients and healthy controls: effects of heparin.


V. Jankowski: Isolation, identification and characterization of vasoactive substances from endothelial cells, platelets and mononuclear cells.


P. Jonsson: Safety and biological aspects of present techniques of haemodialysis.


E. Schepers: In vitro research for the pathophysiological mechanisms of uremic retention solutes on leukocytes in relation to chronic inflammation and accelerated atheromatosis in chronic kidney diseases.


T. Guenthner:"Angioprotectin": a vasoprotective angiotensin peptide".

M. Koehler: Contribution of known uremic retention solutes to the development of cardiovascular diseases in patients with chronic kidney disease.

E. Houthuys: Transcriptome analysis of monocytes and macrophages in mycobactrial infection and chronic kidney disease.

M. Luman: Dialysis Dose and Nutrition Assessment by an Optical Method.


N. Meert: Optimisation of removal of uremic retention solutes by haemodialysis strategies.


S. Salem: Isolation and identification of vasomodulating biomolecules

A. Pletinck: The peritoneal membrane as a window for microvascular pathophysiology in chronic kidney disease.


F. Duranton: Natural history of chronic kidney disease. Analysis of pathophysiological and prognostic factors of renal failure and its complications.

J. Holmar: Optical Method for Uric Acid Removal Assessment During Dialysis.

B. Holmberg: Analysis of risk factors in patients with severe chronic kidney disease. The role of atovastatin.

D. Mahmood: Lipoprotein lipase activity is reduced in dialysis patients. Studies on possible causal factors.

U. Forsberg: Presence of microemboli during haemodialysis and methods to reduce the exposure to microbubbles.


F. Böhringer: Development of clinical methods for increased removal of protein-bound uremic toxins in the context of an extracorporeal therapy.

J. Boelaert: Development of metabolic analytical platforms for the characterization of uremic retention compounds.


N. Neirynck: Micro-inflammation and cardiovascular disease in chronic kidney disease: role of uremic peptides,

J. Siwy: Validation of an urinary classifier for diagnosis of diabetic nephropathy.


M. Rueth: Hydrophobe Metabolite: Proteinaffinität, Quantifizierung und Methodische Ansätze zur Untersuchung vaskulärer Effekte. Major Chromophores and Fluorophores in the Spent Dialysate as Cornerstones for Optical Monitoring of Kidney Replacement Therapy.

J. Arund: Major Chromophores and Fluorophores in the Spent Dialysate as Cornerstones for Optical Monitoring of Kidney Replacement Therapy.

A. Bhat: Bioinformatics Modeling of Proteomics changes in Muscle Invasive Bladder Cancer.

A. Latosinska: Optimizing methodologies for clinical proteomics.

M. Pejchinovski: The role of urinary peptide markers in diagnosis and prognosis of servere renal diseases.

S. Filip: Identification of protein biomarkers for chronic kidney disease progression using state-of-the-art proteomics approaches.

O. A. Deif: Documentation and evaluation of uremic retention solutes through an interactive database


C. Pontillo: Clinical peptidomics of non-invasive diagnosis and prognosis of renal diseases.

R. Tomson: Urea- and Creatinine-Based Parameters in the Optical Monitoring of Dialysis: The Case of Lean Body Mass and Urea Rebound Assissment.

N. Chevtchik: Development of an upscaled bioatificial kidney.


D. Pavlenko: Towards Improved Removal of Uremic Toxins from Human Plasma

S. Kalle: Optical Monitoring of Uremic Metabolites-Fluorophores during Dialysis: the Case of ß2-microglobulin, Pentosidine, and 4-Pyridoxic Acid.

O. Deltombe: Kinetics of protein-bound uremic toxins in chronic kidney disease.




Upcoming Events















Webmaster: V.Jankowski

last change:
15.06.2019 11:09 PM

- Scientists from Academia
- Previous EUTox Meetings
- Scientists from Industry
- Members emeritus